Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
SCHAFFHAUSEN, Switzerland, April 5, 2017 /CNW/ - Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its...
SCHAFFHAUSEN, Switzerland, June 2, 2016 /CNW/ - Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its...
JENA, Germany, Nov. 26, 2014 /CNW/ - Occlutech, a leading European innovator of products to treat structural heart disease today announced that it is making its range of PFO and ASD occluders...
JENA, Germany, Sept. 29, 2014 /CNW/ - Occlutech, a leading innovator of products to treat structural heart disease today announced that it has obtained a European CE Mark approval for its dedicated...
JENA, Germany, July 23, 2014 /CNW/ - Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced that it has successfully obtained...
SCHAFFHAUSEN, Switzerland, Oct. 22, 2012 /CNW/ - The European Tech Tour Association, an independent, not-for-profit organization committed to the development of emerging technology companies from...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.